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Zn2+ is an essential nutrient for all known forms of life. In the major human
pathogen Streptococcus pneumoniae, the acquisition of Zn2+ is facilitated by two
Zn2+-specific solute-binding proteins: AdcA and AdcAII. To date, there has
been a paucity of structural information on AdcA, which has hindered a deeper
understanding of the mechanism underlying pneumococcal Zn2+ acquisition.
Native AdcA consists of two domains: an N-terminal ZnuA domain and a
C-terminal ZinT domain. In this study, the ZnuA domain of AdcA was
crystallized. The initial crystals of the ZnuA-domain protein were obtained
using dried seaweed as a heterogeneous nucleating agent. No crystals were
obtained in the absence of the heterogeneous nucleating agent. These initial
crystals were subsequently used as seeds to produce diffraction-quality crystals.
The crystals diffracted to 2.03 A˚ resolution and had the symmetry of space
group P1. This study demonstrates the utility of heterogeneous nucleation. The
solution of the crystal structures will lead to further understanding of Zn2+
acquisition by S. pneumoniae.
1. Introduction
First-row transition-metal ions are essential for all known
forms of life (Klein & Lewinson, 2011). Bacterial acquisition
of essential transition metals is generally achieved by metal-
specific solute-binding proteins (SBPs; Klein & Lewinson,
2011; Counago et al., 2012). SBPs reside on the extracytosolic
side of bacterial cells (Sutcliffe & Russell, 1995; Adler, 1975)
and deliver metal-ion cargoes to specific ATP-binding cassette
permeases, which then facilitate active transport of the ions
across the cytoplasmic membrane (Davidson et al., 2008; Rees
et al., 2009). The SBPs involved in the acquisition of transition-
metal ions are generally defined by an overall structure
comprising two globular (/)4 lobes, referred to as the
N-terminal and C-terminal lobes, that are linked by a rigid
-helix that spans the length of the protein (Lawrence et al.,
1998; Li & Jogl, 2007; Loisel et al., 2008; Rukhman et al., 2005;
Sun et al., 2009). The metal-binding site is formed by the
interface between the two lobes (Klein & Lewinson, 2011).
Streptococcus pneumoniae is the world’s foremost bacterial
pathogen and is responsible for more than one million deaths
annually (McDevitt et al., 2011). Zinc, among other transition
metals, is an essential nutrient for the survival and virulence of
S. pneumoniae (Coleman, 1998; Yang et al., 2006; Ammendola
et al., 2007). Pneumococcal uptake of Zn2+ is facilitated by
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the ATP-binding cassette transporter AdcCB and the two
Zn2+-specific SBPs AdcA and AdcAII (Bayle et al., 2011;
Plumptre et al., 2014). However, the lack of an experimentally
determined structure of AdcA has greatly limited our under-
standing of its role in Zn2+ acquisition by S. pneumoniae.
Sequence-alignment and secondary-structure analyses have
shown that AdcA consists of two domains: an N-terminal
domain (ZnuA domain), which resembles the Zn2+-specific
SBP ZnuA from Gram-negative bacteria, and a C-terminal
domain (ZinT domain), which is homologous to ZinT, a Zn2+-
binding protein present in Gram-negative species. Recent
studies have proposed that the ZnuA domain of AdcA
acquires Zn2+ and initiates Zn2+ transport, whereas the ZinT
domain of AdcA acts as a Zn2+ chaperone to enhance the
Zn2+-acquisition efficiency of AdcA during severe Zn2+
shortage (Plumptre et al., 2014). To understand the structural
basis of AdcA-facilitated Zn2+ acquisition in S. pneumoniae,
crystallization of the ZnuA domain of AdcA was performed.
Initial attempts using sparse-matrix screens failed to yield
any ZnuA-domain protein crystals. We hypothesized that
the lack of crystals may be owing to inadequate nucleation.
Nucleation is a critical and rate-limiting step in the protein
crystallization process, where a nucleus of protein, aggregated
in such a way as to form favourable molecular contacts, reaches
a critical size. Spontaneous attachment of additional protein
molecules to such a nucleus becomes energetically favourable
and sizable crystals may subsequently form (Rupp, 2010).
However, spontaneous nucleation often requires a specific
narrow range of protein supersaturation levels, which is often
difficult to locate. Furthermore, sparse-matrix screens do not
sample precipitant concentration to a great extent, and the
probability of spontaneous nucleation decreases with small
crystallization solution volumes (Thakur et al., 2007).
Heterogeneous nucleation has been used as a successful
approach to overcome the nucleation problem (McPherson &
Shlichta, 1988; Ino et al., 2011; Tosi et al., 2011; Kertis et al.,
2012; Lin & Merlino, 2013). In heterogeneous nucleation, a
material known as a heterogeneous nucleating agent, or
nucleant, is introduced to the protein solution in a low
supersaturated state. Heterogeneous nucleating agents have
been proposed to provide structured surfaces for the forma-
tion of nuclei and to lower the thermodynamic and kinetic
barriers for spontaneous nucleation (Garcia-Ruiz, 2003; Rupp,
2010). It has been shown in a number of studies that specific
solid materials such as horse hair (D0Arcy et al., 2003; Thakur
et al., 2007), porous silicon (Chayen et al., 2001) and dried
seaweed powder (Thakur et al., 2007) can be used as hetero-
geneous nucleants to promote nucleation. We therefore tested
dried seaweed as a heterogeneous nucleant for the crystal-
lization of the ZnuA domain of AdcA. This approach led to
diffraction-quality crystals.
2. Materials and methods
2.1. Protein production
Two different recombinant S. pneumoniae AdcA ZnuA-
domain constructs were prepared, using the pMCSG7 and
the pCAMnLIC01 vectors, to examine whether the use of
different expression vectors affected protein crystallization.
The pMCSG7 construct corresponded to an N-terminally
hexahistidine-tagged fusion protein encoding residues 27–308
(the ZnuA domain) of AdcA. The AdcA ZnuA-domain
cDNAwas cloned into the pMCSG7 vector using the ligation-
independent cloning technique (Eschenfeldt et al., 2009).
Protein expression was achieved using the auto-induction
protocol (Studier, 2005), and the protein was purified using
an Ni–NTA column (GE Healthcare) and a size-exclusion
column (HiLoad 26/600 Superdex 75 pg, GE Healthcare). The
N-terminal hexahistidine affinity tag was removed by
enzymatic digestion using tobacco etch virus protease at a
cleavage site introduced between the protein sequence and
the affinity tag. The pCAMnLIC01 construct corresponded to
an N-terminally dodecahistidine-tagged fusion protein
encoding residues 27–321 of AdcA and was expressed and
purified as described previously, with minor modifications
(Plumptre et al., 2014). The protein was purified using a
HisTrap HP column on an A¨KTApurifier, followed by
removal of the tag by enzymatic digestion by the 3C human
rhinovirus protease at the cleavage site between the protein
sequence and the tag. The protein was then reverse-purified
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Table 1
Macromolecule-production information.
The underlined protein sequence indicates the artificial amino acids
introduced by cloning. The protease cleavage sites are between the amino
acids in italics.
Source organism S. pneumoniae D39
DNA source S. pneumoniae D39
Forward primers
pMCSG7 50-TACTTCCAATCCAATGCCGGTAAACTCAATA-
TCGTGACAACCTTTTACCCTG-30
pCAMnLIC01 50-TGGGTGGTGGATTTCCTGGTAAACTCAATAT-
CGTGACA-30
Reverse primers
pMCSG7 50-TTATCCACTTCCAATGTTATGTTTGTTTCAA-
AGCCTTGAGGTTTTTCTCC-30
pCAMnLIC01 50-TTGGAAGTATAAATTTCCATGCGCCAACATT-
TCTTGGGC-30
Cloning vector pMCSG7, pCAMnLIC01
Expression vector pMCSG7, pCAMnLIC01
Expression host E. coli BL21 (DE3)
Complete amino-acid sequence
of the pMCSG7 construct
produced
GDIHMHHHHHHSSGVDLGTENLYFQSNADGKLNI-
VTTFYPVYEFTKQVAGDTANVELLIGAGTEPH-
EYEPSAKAVAKIQDADTFVYENENMETWVPKL-
LDTLDKKKVKTIKATGDMLLLPGGEEEEGDHD-
HGEEGHHHEFDPHVWLSPVRAIKLVEHIRDSL-
SADYPDKKETFEKNAAAYIEKLQSLDKAYAEG-
LSQAKQKSFVTQHAAFNYLALDYGLKQVAISG-
LSPDAEPSAARLAELTEYVKKNKIAYIYFEEN-
ASQALANTLSKEAGVKTDVLNPLESLTEEDTK-
AGENYISVMEKNLKALKQTTD
Complete amino-acid sequence
of the pCAMnLIC01
construct produced
MGTHHHHHHHHHHHHSAGLEVLFQGPGGSLGGGF-
PGKLNIVTTFYPVYEFTKQVAGDTANVELLIG-
AGTEPHEYEPSAKAVAKIQDADTFVYENENME-
TWVPKLLDTLDKKKVKTIKATGDMLLLPGGEE-
EEGDHDHGEEGHHHEFDPHVWLSPVRAIKLVE-
HIRDSLSADYPDKKETFEKNAAAYIEKLQSLD-
KAYAEGLSQAKQKSFVTQHAAFNYLALDYGLK-
QVAISGLSPDAEPSAARLAELTEYVKKNKIAY-
IYFEENASQALANTLSKEAGVKTDVLNPLESL-
TEEDTKAGENYISVMEKNLKALKQTTDGNLYF-
QGPWKLD
on a HisTrap HP column, with the cleaved protein eluting in
the absence of imidazole. The purified protein from both
constructs was concentrated to 10 mg ml1 using a centrifugal
filter unit (molecular-weight cutoff 10 or 30 kDa; Millipore) in
a buffer solution consisting of 150 mM NaCl, 25 mM Tris pH
8.0, 5%(v/v) glycerol. Protein concentration was determined
by spectrophotometry (absorbance measured at 280 nm) using
a NanoDrop 2000 spectrophotometer (Thermo Scientific).
The molar extinction coefficient of the protein,
30 370M1 cm1, was calculated using the ExPASy server
(Gasteiger et al., 2003). Details of the macromolecule-
production information are summarized in Table 1.
2.2. Crystallization
Heterogeneous nucleation was performed using the
protocol of Thakur et al. (2007) with minor changes. Seaweed
was used as the source of the heterogeneous nucleation agent.
Fresh green seaweed was purchased from a local store, washed
thoroughly and dried overnight at 343 K. The dried seaweed
was crushed into a fine powder with a pre-chilled mortar and
pestle. During crushing, liquid nitrogen was added to the
mortar to maintain the low temperature. Roughly 100 mg of
the crushed seaweed powder was added to 200 ml of
10 mg ml1 protein solution and the mixture was used for
sparse-matrix screens and optimization experiments.
Commercially available sparse-matrix screens, including
Index, PEG/Ion, PEGRx (Hampton Research), Precipitant
Synergy (Rigaku), JCSG, MORPHEUS, PACT and ProPlex
(Molecular Dimensions), were set up at the University of
Queensland Remote Operation Crystallization and X-ray
Diffraction (UQ-ROCX) Facility using a Mosquito robot
(TTP Labtech) in a 96-well hanging-drop vapour-diffusion
plate format with 100 nl protein and 100 nl reservoir solution
per drop. The plates were incubated using a Rock Imager
(Formulatrix) at 293 K and the drops were monitored
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Figure 1
Crystallization of the AdcA ZnuA domain monitored from 0 to 96 h after experiment setup using MORPHEUS condition A4 [12.5%(w/v) PEG 1000,
12.5%(w/v) PEG 3350, 12.5%(v/v) 2-methyl-2,4-pentanediol, 0.03M MgCl2, 0.03M CaCl2, 0.1M imidazole–MES pH 6.5] as the reservoir solution at
293 K and using dried seaweed as a heterogeneous nucleating agent. Images were obtained using the Rock Imager at the UQ-ROCX Facility at the
University of Queensland.
regularly. A hit was obtained using the MORPHEUS screen,
with the reservoir solution consisting of 12.5%(w/v) poly-
ethylene glycol (PEG) 1000, 12.5%(w/v) PEG 3350,
12.5%(v/v) 2-methyl-2,4-pentanediol, 0.03M MgCl2, 0.03M
CaCl2, 0.1M imidazole–MES pH 6.5. The initial crystallization
conditions were subjected to optimization in order to obtain
diffraction-quality crystals. A series of combinations, varying
the precipitant and protein concentration, the buffer pH and
the incubation temperature, were explored in 24-well hanging-
drop vapour-diffusion plate format. Droplets with different
drop sizes were equilibrated against 1 ml reservoir solution at
the chosen temperatures (277, 291 or 293 K). The micro-
seeding technique was also employed using the Seed Bead kit
(Hampton Research); the original needle-like crystals were
collected from the crystallization drop and transferred to a
pre-chilled Seed Bead tube, which is a 1.5 ml microcentrifuge
tube containing a polytetrafluoroethylene bead and 50 ml
crystallization solution. The Seed Bead tube was then
vortexed to obtain a homogeneous solution with fine micro-
crystalline seeds. Different volumes (0.2–0.5 ml) of seeds were
subsequently added to the crystallization drops while setting
up the plates.
2.3. Data collection and processing
Diffraction data were collected on the MX1 beamline at the
Australian Synchrotron. The data set was collected using a
total oscillation range of 360 with 0.5 oscillations and 1 s
X-ray exposure per image. The data were indexed and inte-
grated usingXDS (Kabsch, 2010) and merged and scaled using
AIMLESS from the CCP4 suite (Winn et al., 2011; Evans &
Murshudov, 2013). Initial phases were obtained by molecular
replacement using Phaser in the PHENIX suite (Adams et al.,
2010; McCoy et al., 2007) with the crystal structure of ZnuA
from Escherichia coli (sequence identity 23%; PDB entry
2ps0; Yatsunyk et al., 2008) as the search model.
3. Results and discussion
The ZnuA domain of AdcAwas overexpressed in E. coli BL21
cells using the pMCSC7 vector and purified by immobilized
metal-ion affinity chromatography and gel filtration. The
N-terminal hexahistidine tag was removed by proteolysis
using TEV protease prior to gel filtration. The final yield was
7 mg per litre of bacterial culture, which was sufficient for
subsequent crystallization experiments. A protein concentra-
tion of 10 mg ml1 was used to set up the initial sparse-matrix
screens containing 100 nl protein with 100 nl reservoir solu-
tion in the drop using the hanging-drop format. The screens
were prepared using a Mosquito crystallization robot (TTP
Labtech) and were incubated at 293 K. However, crystal-
lization of the ZnuA domain did not occur under any of the
768 conditions tested 21 d after experiment setup. Crystal-
lization of a second preparation of the protein, expressed
using the in pCAMnLIC01 vector, was similarly unsuccessful.
The homogeneity of the protein samples was estimated to be
suitable for crystallization, as indicated by the single gel band
on SDS–PAGE and a narrow, symmetrical peak on gel filtra-
tion. The lack of protein crystals suggested that the conditions
sampled in the initial screening may not have been suitable
for spontaneous nucleation of the ZnuA-domain protein. To
promote nucleation, dried seaweed powder was introduced
into the initial screening drops as a heterogeneous nucleating
agent, following the method suggested by Thakur et al. (2007).
This led to successful crystallization of the protein for both
constructs (Fig. 1). 24 h after experiment setup, thin needle-
shaped crystals started to appear from the seaweed residuals
with 12.5%(w/v) PEG 1000, 12.5%(w/v) PEG 3350, 12.5%(v/v)
2-methyl-2,4-pentanediol, 0.03M MgCl2, 0.03M CaCl2, 0.1M
imidazole–MES pH 6.5 (MORPHEUS condition A4) as the
reservoir solution. The needle crystals of the ZnuA-domain
protein were reproduced in larger scale crystallization
drops (1.5 ml protein + 1.5 ml crystallization solution) using
research communications
1462 Luo et al.  ZnuA domain of pneumococcal AdcA Acta Cryst. (2015). F71, 1459–1464
Figure 2
Crystal optimization of the AdcA ZnuA domain using the micro-seeding technique. (a) Crystal grown on the surface of dried seaweed powder in a 3 ml
crystallization drop (1.5 ml protein + 1.5 ml reservoir solution). (b) Crystals with improved size and shape obtained using the crystals in (a) as seeds. The
crystals were obtained at 293 K 48 h after seeding. In both cases the reservoir solution corresponded to 12.5%(w/v) PEG 1000, 12.5%(w/v) PEG 3350,
12.5%(v/v) 2-methyl-2,4-pentanediol, 0.03M MgCl2, 0.03M CaCl2, 0.1M imidazole–MES pH 6.5.
crystallization solution prepared in-house in the presence of
dried seaweed powder. It could clearly be seen that the crys-
tals grew on the surface of the seaweed residuals (Fig. 2a).
These imperfect crystals were subsequently used for micro-
seeding using equivalent crystallization conditions as in the
original crystallization trials to obtain crystals with improved
morphology and size (Fig. 2b). It was noted that when
harvesting the initial crystals for micro-seeding, tiny pieces of
seaweed in the drops could also have been picked up and the
final crystals produced by a combination of homogeneous and
heterogeneous nucleation. These improved crystals were then
tested for diffraction at the Australian Synchrotron. The
crystals diffracted to 2.03 A˚ resolution and a data set was
collected from a single crystal. The diffraction pattern is shown
in Fig. 3.
The ZnuA-domain crystals have the symmetry of space
group P1, with unit-cell parameters a = 60.37, b = 67.96,
c = 79.62 A˚,  = 92.27,  = 104.7,  = 116.0. It is most likely
that there are four protein molecules in the asymmetric unit,
corresponding to a Matthews coefficient of 2.3 A˚3 Da1 and a
solvent content of 45.9%. Detailed diffraction statistics are
summarized in Table 2. To obtain phase information, mole-
cular replacement was carried out in Phaser with the crystal
structure of Zn2+-bound ZnuA from E. coli (PDB entry 2ps0;
Yatsunyk et al., 2008) as a search model. A solution was found
with a translation-function Z-score of 21.3 and a log-likelihood
gain of 7741. Structure refinement is currently in progress.
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